Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
Canada · Delayed Price · Currency is CAD 11.30
-0.15 (-1.31%)
Sep 24, 2026, 10:54 AM EST
Eupraxia Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Initiates $23.99 | Buy | Initiates | $23.99 | +112.27% | Sep 24, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $35.27 | Buy | Reiterates | $35.27 | +212.16% | Sep 24, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $15.52 | Buy | Maintains | $15.52 | +37.35% | Sep 22, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 27, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $22.58 | Buy | Maintains | $22.58 | +99.79% | Aug 27, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $26.81 | Buy | Reiterates | $26.81 | +137.25% | Aug 12, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $23.99 | Buy | Maintains | $23.99 | +112.27% | Aug 12, 2026 |
| Bloom Burton | Bloom Burton | Buy Maintains $19.75 | Buy | Maintains | $19.75 | +74.81% | Aug 3, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.